Perelman School of Medicine at the University of Pennsylvania

Center for Research on Reproduction and Women's Health

Robert Allen Burger

faculty photo
Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania
Director of Clinical Research, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Perelman School of Medicine
Professional Medical Staff, Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
Director of Gynecologic Oncology Fellowship Program, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Perelman School of Medicine
Department: Obstetrics and Gynecology

Contact information
University of Pennsylvania
3400 Civic Center Blvd.
Smilow CTR 8-104
Philadelphia, PA 19104-5156
Office: 215-746-4043
Fax: 215-573-5129
Education:
A.B. (Biochemistry)
Harvard University, Cambridge, MA, 1984.
M.D.
New York University, New York, NY, 1988.
Post-Graduate Training
Resident, Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania , 1988-1992.
Fellow, Gynecologic Oncology, University of California, Irvine, Irvine, California , 1992-1996.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Burger RA, Deng W, Makker V, Collins Y, Gray H Debernardo R, Martin LP, Aghajanian C.: Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Group Study Gynecol Oncol In Press, Jun 2018.

Penson RT, Moore KN, Herzog TJ, Burger RA, Freedman LS, Lowenton-Spier N, Harats D, Sher N, Cohen YC, Monk BJ.: Clinical trial in progress: A study of VB-111 combined with paclitaxel vs. paclitaxel for treatment of recurrent platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018). Annual Meeting of the American Society of Clinical Oncology (Oral Presentation), Chicago, IL {Abstract} Jun 2018.

Burger RA, Enserro D, Tewari KS, Brady MF, Bookman MA, Fleming GF, Huang HQ, Homesley HD, Fowler J, Boente M, Randall LM, Chan JK, Ferris JS, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ : Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study. Annual Meeting of the American Society of Clinical Oncology (Oral Presentation), Chicago, IL. (Abstract) Jun 2018.

Buechel M, Enserro D, Burger RA, Brady MF, Wade K, Alvarez Secord A, Nixon AB, Mirniaharikandehei S, Liu H, Zheng B, Gray G, Tewari KS, O'Malley DM, Mannel RS, Moore KN, Birrer MJ: Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis. Annual Meeting of the American Society of Clinical Oncology (Oral Presentation), Chicago, IL. (Abstract) Jun 2018.

Arend RC, Toboni M, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, Herzog T.: Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm. The Oncologist In Press, Jun 2018.

Cory L, Bogner H, Burger R, Chu C, Ko E.: Targeted Educational Interventions Increase Human Papillomavirus Vaccine Acceptability and Knowledge. Oral presentation at: ACOG Annual Clinical and Scientific Meeting; Austin, TX. Abstract Apr 2018.

Eskander RN, Kauderer J, Tewari KT, Mannel RS, Bristow RE, O'Malley DM, Rubin SC, Glaser GE, Hamilton CA, Fujiwara K, Huh WK, Ueland F, Stephan J-M, Burger RA : Correlation between surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study Gynecol Oncol In Press, Mar 2018.

Gockley AA, Cronin A, Bookman MA, Burger RA, Cristea M, Griggs JJ, Mantia-Smaldone GM, Meyer LA, O'Malley DM, Wright AA.: Outcomes of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) Mar 2018.

Cory L, Brensinger CM, Haggerty AF, Giuntoli RL II, Latif NA, Burger RA, Morgan MA, Lin LL, Ko EM.: Differences in overall survival associated with type and sequence of adjuvant therapy in stage I uterine carcinosarcoma. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) Mar 2018.

Roy AG, Brensinger CM, Lin LL, Giuntoli RL II, Haggerty AF, Latif NA, Burger RA, Morgan MA, Ko EM.: Endometrial cancer survival outcomes differ by geographical region. Poster presentation at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) Mar 2018.

back to top
Last updated: 06/15/2018
The Trustees of the University of Pennsylvania